|
|
 | | | |
- close
- close
- close
- close
| |||||||||
These excerpts taken from the CBRX 10-K filed Mar 16, 2009. Vaginal Moisturizer. Our BDS
vaginal gel, without an active pharmaceutical ingredient, is sold as Replens
Vaginal Moisturizer. Replens is indicated for replenishment of vaginal moisture
on a sustained basis and to relieve the discomfort associated with vaginal
dryness. Replens was the first product developed utilizing the BDS. In May 2000,
the Company sold the U.S. rights for Replens to Lil’ Drug Store Products, Inc.
(“Lil’ Drug Store”), pursuant to an agreement under which the Company received
royalties of 10% of sales of Replens in the U.S until October 2005. On June 29,
2004, the Company sold the remaining worldwide marketing rights for Replens to
Lil’ Drug Store and executed two related agreements with Lil’ Drug Store: a five
year supply agreement for Lil’ Drug Store’s requirements for Replens in non-U.S.
markets that expires October 31, 2009, and a promotion agreement that expired at
the end of 2006. See “Licensing and Development Agreements.”
Vaginal Moisturizer. Our BDS vaginal gel, without an active pharmaceutical ingredient, is sold as Replens Vaginal Moisturizer. Replens is indicated for replenishment of vaginal moisture on a sustained basis and to relieve the discomfort associated with vaginal dryness. Replens was the first product developed utilizing the BDS. In May 2000, the Company sold the U.S. rights for Replens to Lil’ Drug Store Products, Inc. (“Lil’ Drug Store”), pursuant to an agreement under which the Company received royalties of 10% of sales of Replens in the U.S until October 2005. On June 29, 2004, the Company sold the remaining worldwide marketing rights for Replens to Lil’ Drug Store and executed two related agreements with Lil’ Drug Store: a five year supply agreement for Lil’ Drug Store’s requirements for Replens in non-U.S. markets that expires October 31, 2009, and a promotion agreement that expired at the end of 2006. See “Licensing and Development Agreements.” | EXCERPTS ON THIS PAGE:
RELATED TOPICS for CBRX: |
| |||||||
